Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,954
Closed -$232K 806
2025
Q1
$232K Hold
4,954
0.01% 719
2024
Q4
$254K Sell
4,954
-633
-11% -$32.8K 0.01% 699
2024
Q3
$248K Sell
5,587
-539
-9% -$23.6K 0.01% 699
2024
Q2
$246K Hold
6,126
0.01% 686
2024
Q1
$245K Hold
6,126
0.01% 685
2023
Q4
$231K Buy
+6,126
New +$187K 0.01% 688
2023
Q1
Sell
-10,974
Closed -$412K 691
2022
Q4
$412K Sell
10,974
-1,873
-15% -$74.4K 0.04% 458
2022
Q3
$481K Sell
12,847
-607
-5% -$24.1K 0.08% 305
2022
Q2
$485K Buy
13,454
+8,279
+160% +$343K 0.08% 302
2022
Q1
$253K Hold
5,175
0.03% 477
2021
Q4
$248K Buy
+5,175
New +$245K 0.07% 314

Other funds holding SNV

Metis Global Partners's SNV Position: Q2 2025 in Review

Metis Global Partners sold out of Synovus (SNV) in Q2 2025, closing a stake of 4,954 shares — an estimated $232K sold.

Metis Global Partners first reported a position in SNV in Q4 2021 and held it in 11 quarters. The position peaked at $485K in Q2 2022. 475 funds tracked by Wall St. Rank hold SNV as of Q2 2025.

  • Metis Global Partners reported no remaining Synovus position as of Q2 2025 after selling out during the quarter.
  • Metis Global Partners sold 4,954 Synovus shares in Q2 2025, an estimated $232K.
  • Metis Global Partners first reported a position in Synovus in Q4 2021 and held it in 11 quarters.
  • Metis Global Partners's Synovus position peaked at $485K in Q2 2022.
  • 475 funds tracked by Wall St. Rank held Synovus as of Q2 2025.

Based on Metis Global Partners's 13F filing for Q2 2025, filed 6 Aug 2025.